Effect of dual ??-blockade and calcium antagonism on endurance performance

Publisher Website
Google Scholar
Abstract
GORDON, N. F., J. P. VAN RENSBURG, D. P. VAN DEN HEEVER, N. B. KALLIATAKIS, and D. P. MYBURGH. Effect of dual β-blockade and calcium antagonism on endurance performance. Med. Sci. Sports Exerc., Vol. 19, No. 1, pp. 1–6, 1987. The effect of oral clinically used doses of propranolol, atenolol, nifedipine, propranolol + nifedipine, and atenolol + nifedipine on endurance performance and ventilatory responses to graded treadmill testing was studied in 12 healthy physically active men. Maximal exercise duration was reduced by propranolol (8.5%, P < 0.001) and its combination with nifedipine (11.1%, P < 0.001), and to a lesser degree by atenolol (3.2%, 0.05 < P < 0.1), nifedipine (2.1%, P < 0.05), and atenolol + nifedipine (3.9%, P < 0.01). Exercise duration and heart rate (HR) and ventilatory responses to maximal exercise were equivalent with a β-blockade reduced the HR and oxygen uptake, nifedipine accentuated the HR but did not alter ventilation, and all drugs modified the relative oxygen uptake corresponding to 85% of the maximal HR. Physiologic responses to submaximal exercise during combination therapy were similar to those during β-blockade alone. This study concludes that, in physically active men, nifedipine induces a small impairment of maximal performance, but does not accentuate the reduction in effort tolerance resulting from β-blockade. Furthermore, HR and ventilatory responses to exercise during combined β-blockade and calcium antagonism can be predicted from those during β-blockade alone.

This publication has 0 references indexed in Scilit: